My passion for working in the field of bone marrow transplantation (BMT) stems from a long-standing curiosity about how to better harness the immune system to treat cancer. Through BMT, we are able to treat a number of blood-related diseases that would otherwise be incurable. The opportunity to improve the efficacy and safety of BMT inspires me to specialize in this area of medicine. I’m always on the lookout for innovative therapeutic approaches that may benefit my patients.
One of my fondest memories as a physician was when I had the privilege of working with an elderly woman who had traveled to the U.S. to seek treatment for lymphoma. She persevered through tough chemotherapy treatments and remained upbeat despite the obstacles she faced. Her positive attitude was inspiring. Our whole team was proud to have helped her through this rough time in her life, and ultimately we were able to get her back to her home country in remission. I believe in respecting every patient’s individual life circumstances, desires, goals and feelings about their illness so that we can personalize their treatment plan and help them achieve the best possible outcome.
Area of Clinical Practice
Malignant and non-malignant blood disorders
I am a board-certified hematologist who specializes in caring for patients undergoing bone marrow transplantation. As a physician-scientist, I spend part of my time in a laboratory setting studying the immune system. My research is focused on how T cells, which play a central role in the development of post-transplant conditions such as graft-versus-host disease, grow and expand after a transplant. Learning more about the role T cells play in the recovery of the immune system can help us improve treatment outcomes.
Massachusetts General Hospital, Internal Medicine
University of Washington, Hematology-Oncology
Hematology, 2020, ; Internal Medicine, 2017, American Board of Internal Medicine
NIH K08 Award
Dr. Yeh received this award in 2023 from the National Institute of Health. This is a five-year research career development program focused on the study of T-cell reconstitution following hematopoietic stem cell transplantation and how graft-vs-host disease can be shaped by clonotypic response to microbiota.
ASTCT New Investigator Award
Dr. Yeh received this award in 2023 from the American Society of Transplantation and Cellular Therapy. The award supports the work of young investigators in the field of blood and marrow transplantation and cellular therapy. Dr. Yeh’s project, titled "Microbiota specific donor CD4+ T cells modulate graft vs. host disease (GVHD)", seeks to understand how differences in the microorganisms within transplant donors and recipients can impact GVHD.
ASH Research Training Award for Fellows
Dr. Yeh received this award in 2020 from the American Society of Hematology. The award supports the work of junior researchers in hematology and hematology-related fields.
At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.